(PharmaNewsWire.Com, May 12, 2017 ) Publisher€™s market research analyst has estimated this market to show steady growth during the forecast period. The prospect for growth in this market is dependent on factors like the high incidence of vitamin D deficiency among the populace in this region, which results in its slow but moderate CAGR of around 4% by 2019.
The prevention of various acute and chronic diseases is the key driver for the growth of this market. Vitamin D deficiency can lead to various chronic diseases like rickets and osteoporosis, and can also result in cardiovascular diseases, cancer, asthma in infants, cognitive disorders, and autoimmune diseases. The incidence of these diseases can be reduced by frequently testing the vitamin D levels, which in turn would help to reduce the overall healthcare expenditure.
Application-based segmentation and analysis of - 25-Hydroxy vitamin D tests & 1,25-Dihydroxy vitamin D test
In this market research report, analysts estimate the 25-Hydroxy vitamin D tests segment to be the largest market segment during the forecast period. Currently, this market segment accounts for a share of nearly 76% and is envisaged to retain its dominating hold over the market by 2019. The ability of 25-Hydroxy vitamin D tests to identify bone malformations and softness, bone weakness, or fractures in adults is one of the most significant factors that accounts for its high market share during the forecast period.
The report offers an analysis of each of the following segments and discusses its impact on the overall market growth -
25-Hydroxy vitamin D tests 1,25-Dihydroxy vitamin D test Competitive landscape and key vendors - Roche Diagnostics, Abbott Diagnostics
This market is highly competitive and consists of vendors that focus on test development and research. These vendors compete on the basis of price, quality, and breadth of product line, technology, and distribution capabilities to gain maximum prominence in the market.
Roche Diagnostics Abbott Diagnostics Siemens Healthcare Diagnostics Biomeriux Diasorin Quest Diagnostics Other prominent vendors analyzed in this market research are Diazyme laboratories, Biokit, ESA Biosciences, Quest Diagnostics Inc., The Vitamin D Company, Tosoh Bioscience Inc., Qualigen Inc., Dade Behring, DIAsource ImmunoAssays S.A, Ortho-Clinical Diagnostics, Piramal Healthcare, Beckman Coulter, and Becton Dickinson.
Growth drivers, challenges, and upcoming drivers - Vitamin D
Upcoming trends such as the augmented adoption of home vitamin D testing kits are rapidly gaining popularity as they are highly cost efficient. Since this market is facing declining reimbursement, patients have to pay out of their pockets to perform these tests. Therefore, in recent times, it has been observed that many patients prefer carrying out such tests at the convenience of their homes as it reduces the overall expenditure.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
